← Back to Search
A Double-blind Cross-over Trial Of A Mucin-containing Artificial Saliva
A. Duxbury, N. Thakker, D. Wastell
Published 1989 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
A double-blind, five phase, cross-over clinical trial was used to compare a mucin-based artificial saliva (Saliva Orthana) with its non-mucin base and water. Thirty patients, acting as their own controls, took part. Saliva Orthana offered significantly greater relief from xerostomia compared with its base or water, and was significantly better at relieving soreness than water. In terms of overall preference, it was ranked significantly higher than either alternative
This paper is referenced by
Xerostomia in terminally ill and dying patients: best practice
Lisa Sheehy (2012)
Clinical trial of a mucin-containing oral spray for treatment of xerostomia in hospice patients
M. Sweeney (1997)
Viscosity and wettability of animal mucin solutions and human saliva.
M. Park (2007)
Nurse maintenance of oral hygiene.
G. Thurgood (1994)
Mucin biopolymers as broad-spectrum antiviral agents.
O. Lieleg (2012)
A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact
S. Jensen (2010)
A new assessment in vitro of human salivary lubrication using a compliant substrate.
R. Gans (1990)
Influences of animal mucins on lysozyme activity in solution and on hydroxyapatite surfaces.
Won-Kyu Park (2006)
Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer.
J. Johnson (1993)
Managing complications of radiation therapy in head and neck cancer patients: Part I. Management of xerostomia.
W. C. Ngeow (2006)
(xerostomia) in Sjögren's syndrome Treatment of oral dryness related complaints
W. V. D. Reijden (2006)
Influences of Animal Mucins on Peroxidase Activity in Solution and on the Surface of Hydroxyapatite
S. Lee (2008)
New Frontiers: Hyperbaric Oxygen Therapy (HBO) in Open Heart Surgery’s Complications
M. Botta (1996)
Physical and biological properties of yam as a saliva substitute.
M. Park (2010)
Clinical and antimicrobial evaluation of a mouthwash and toothpaste for xerostomia: a randomized, double-blind, crossover study.
M. López-Jornet (2011)
Yam tuber mucilage as a candidate substance for saliva substitute: in vitro study of its viscosity and influences on lysozyme and peroxidase activities.
H. Kho (2014)
Preparation of Artificial Saliva Formulation
A. Amal (2015)
Interventions for the management of dry mouth: topical therapies.
S. Furness (2011)
The mouth and palliative care
M. Sweeney (2000)
Etiology, evaluation, and management of xerostomia.
J. W. Millsop (2017)
An in-vitro comparative study of wettability of four commercially available saliva substitutes and distilled water on heat-polymerized acrylic resin
N. Sharma (2008)
Bioadhesive, rheological, lubricant and other aspects of an oral gel formulation intended for the treatment of xerostomia.
H. Kelly (2004)
Oral Care for Patients With Cancer: A Review of the Literature
M. Miller (2001)
World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction: prevalence, diagnosis, and treatment
A. Villa (2015)
Effects of carboxymethylcellulose (CMC)-based artificial saliva in patients with xerostomia.
D.-J. Oh (2008)
Salivary Gland Hypofunction and Xerostomia in Head and Neck Radiation Patients.
S. B. Jensen (2019)
Effects of molecular weight of hyaluronic acid on its viscosity and enzymatic activities of lysozyme and peroxidase.
J. Kim (2018)
The cause and management of burning mouth condition.
R. Basker (1991)
O EFEITO DE FRUTAS CÍTRICAS NO FLUXO SALIVAR
E. Saúde (2001)
Treatment of xerostomia with polymer-based saliva substitutes in patients with Sjögren's syndrome.
W. A. van der Reijden (1996)
Influences of Saliva Substitutes on Salivary Enzymatic Activity
H. Kho (2009)
Mucins as multifunctional building blocks of biomaterials.
Georgia Petrou (2018)See more